Samuel Bates Martin - Insider Trading & Ownership

Entity
Individual
Location
C/O Celldex Therapeutics, Inc., 53 Frontage Road, Suite 220, Hampton, NJ
Summary
The estimated net worth of Samuel Bates Martin is at least $996K dollars as of June 18, 2024. Samuel Bates Martin is the SVP AND CFO of Celldex Therapeutics, Inc. and owns shares of Celldex Therapeutics, Inc. (CLDX) stock worth about $996K.
All Insider Reports
All Insider Reports

Ownership of Samuel Bates Martin

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CLDX Celldex Therapeutics, Inc. Svp And Cfo $996K -$1.8M -64.4% Jun 14, 2024

Insider Transactions Reported by Samuel Bates Martin:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.